We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alkermes Requests Speedy Review of Drug for Opioid Dependence
Alkermes Requests Speedy Review of Drug for Opioid Dependence
April 16, 2010
Alkermes has asked the FDA to give its sNDA for Vivitrol for treatment of opioid dependence priority review, which would mean a shorter six-month review
period than the standard 10 months.